Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
The portfolio has 2 pending office actions in Biotechnology & Pharmaceuticals. Those matters are distributed across 2 distinct examiners and 2 distinct art units, indicating that the pending work spans separate examination assignments.
FRONDA, CHRISTIAN L is the busiest examiner, with 1 pending matter. Because the activity is divided across examiners and units, counsel should evaluate each matter in its own examination context.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRONDA, CHRISTIAN L | 1 | 82.5% | +14.3% |
| GAVIA, NYLA EMANI ANN | 1 | 77.9% | +17.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18587684 | PURIFICATION METHOD OF MYCOBACTERIUM-DERIVED NANOCARRIER PROTEIN | FRONDA, CHRISTIAN L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18487185 | METHOD FOR AUTOMATICALLY IDENTIFYING EMISSION SOURCES IN SOURCE APPORTIONMENT PROCESS OF POLLUTANTS | GAVIA, NYLA EMANI ANN | 5d overdue |
| 18587684 | PURIFICATION METHOD OF MYCOBACTERIUM-DERIVED NANOCARRIER PROTEIN | FRONDA, CHRISTIAN L | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 2857 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18587684 | PURIFICATION METHOD OF MYCOBACTERIUM-DERIVED NANOCARRIER PROTEIN | FRONDA, CHRISTIAN L | 1656 | §103§112DP | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18487185 | METHOD FOR AUTOMATICALLY IDENTIFYING EMISSION SOURCES IN SOURCE APPORTIONMENT PROCESS OF POLLUTANTS | GAVIA, NYLA EMANI ANN | 2857 | §103 | Final Rejection | 5d overdue | Pending | Oct 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNankai University has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Christian L Fronda has the most, with 1 of Nankai University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
